Future challenges in the elimination of bacterial meningitis

Bottomley, Matthew J.; Serruto, Davide; Sáfadi, Marco Aurelio Palazzi [UNIFESP]; Klugman, Keith P.

Future challenges in the elimination of bacterial meningitis

Date

2012-04-30

Authors

Bottomley, Matthew J.

Serruto, Davide

Sáfadi, Marco Aurelio Palazzi [UNIFESP]

Klugman, Keith P.

item.page.type-of

Artigo

Abstract

Despite the widespread implementation of several effective vaccines over the past few decades, bacterial meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis and Group B Streptococcus (GBS) still results in unacceptably high levels of human mortality and morbidity. A residual disease burden due to bacterial meningitis is also apparent due to a number of persistent or emerging pathogens, including Mycobacterium tuberculosis, Escherichia coli, Staphylococcus aureus, Salmonella spp. and Streptococcus suis. Here, we review the current status of bacterial meningitis caused by these pathogens, highlighting how past and present vaccination programs have attempted to counter these pathogens. We discuss how improved pathogen surveillance, implementation of current vaccines, and development of novel vaccines may be expected to further reduce bacterial meningitis and related diseases in the future. (C) 2011 Elsevier B.V. All rights reserved.

Citation

Vaccine. Oxford: Elsevier B.V., v. 30, p. B78-B86, 2012.